Sana Biotechnology, Inc. (SANA) Misses Q2 EPS by 4c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q2 EPS of ($0.32), $0.04 worse than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• NV Gold closes final tranche of private placement, raising $1.4M
• Future Money Acquisition gets Nasdaq notice over late 10-Q filing